Drug Trial Radar · NCT06727812
Multicenter Phase I Study of HRS-6208 in Patients With Solid Tumors
Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
206
Planned (sponsor's estimate)
Start
Dec 17, 2024
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 11, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open, multicenter Phase I study to evaluate the safety and tolerability of HRS-6208 in patients with advanced solid tumors.
Conditions
- Solid Tumors
Interventions
HRS-6208Drug
HRS-6208.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence and severity of adverse events (AEs)Time frame: From Day 1 to 30 days after the last dose.
- Maximum tolerated dose (MTD)Time frame: From Day 1 to 21 days after the first dose.
- Dose limiting toxicity (DLT)Time frame: From Day 1 to 21 days after the first dose.
- Recommended phase 2 dose (RP2D)Time frame: From Day 1 to 30 days after the last dose.
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China · Recruiting
West China Hospital of Sichuan University
Chengdu, Sichuan, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.